Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Aug;18(8):77.
doi: 10.1007/s11920-016-0710-5.

Dysregulations of Synaptic Vesicle Trafficking in Schizophrenia

Affiliations
Review

Dysregulations of Synaptic Vesicle Trafficking in Schizophrenia

Chijioke N Egbujo et al. Curr Psychiatry Rep. 2016 Aug.

Abstract

Schizophrenia is a serious psychiatric illness which is experienced by about 1 % of individuals worldwide and has a debilitating impact on perception, cognition, and social function. Over the years, several models/hypotheses have been developed which link schizophrenia to dysregulations of the dopamine, glutamate, and serotonin receptor pathways. An important segment of these pathways that have been extensively studied for the pathophysiology of schizophrenia is the presynaptic neurotransmitter release mechanism. This set of molecular events is an evolutionarily well-conserved process that involves vesicle recruitment, docking, membrane fusion, and recycling, leading to efficient neurotransmitter delivery at the synapse. Accumulated evidence indicate dysregulation of this mechanism impacting postsynaptic signal transduction via different neurotransmitters in key brain regions implicated in schizophrenia. In recent years, after ground-breaking work that elucidated the operations of this mechanism, research efforts have focused on the alterations in the messenger RNA (mRNA) and protein expression of presynaptic neurotransmitter release molecules in schizophrenia and other neuropsychiatric conditions. In this review article, we present recent evidence from schizophrenia human postmortem studies that key proteins involved in the presynaptic release mechanism are dysregulated in the disorder. We also discuss the potential impact of dysfunctional presynaptic neurotransmitter release on the various neurotransmitter systems implicated in schizophrenia.

Keywords: Complexin; Munc18; Neurotransmitter; Presynaptic; SNAP-25 (synaptosomal-associated protein 25); SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor); Schizophrenia; Synapsin; Synaptobrevin; Synaptophysin; Syntaxin.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Presynaptic Terminal
Schematic diagram of a presynaptic terminal with synaptic vesicles (SV), showing steps involved vesicle formation, fusion, neurotransmitter release and vesicle recycling via endocytosis at the active zone. Ca2+-channels and other pre and post-synaptic receptors along with the postsynaptic density (PSD) are also shown.
Figure 2
Figure 2. Synaptic Vesicle
Schematic diagram of a synaptic vesicle showing the SNARE and other key proteins involved in vesicular formation, targeting and membrane fusion and recycling at the presynaptic terminals. The arrows indicate the relative expression levels of each protein in schizophrenia when compared to matched controls.

Similar articles

Cited by

References

    1. Keshavan MS. Development, disease and degeneration in schizophrenia: a unitary pathophysiological model. J Psychiatr Res. 1999;33(6):513–21. - PubMed
    1. Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry. 1991;148(10):1301–8. - PubMed
    1. Antonucci F, et al. Reduced SNAP-25 alters short-term plasticity at developing glutamatergic synapses. EMBO Rep. 2013;14(7):645–51. - PMC - PubMed
    1. Anzalone A, et al. Dual control of dopamine synthesis and release by presynaptic and postsynaptic dopamine D2 receptors. J Neurosci. 2012;32(26):9023–34. - PMC - PubMed
    1. Brunelin J, Fecteau S, Suaud-Chagny MF. Abnormal striatal dopamine transmission in schizophrenia. Curr Med Chem. 2013;20(3):397–404. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources